Clinical response to crizotinib retreatment after acquisition of drug resistance

Hiromichi Matsuoka, Takayasu Kurata, Isamu Okamoto, Hiroyasu Kaneda, Kaoru Tanaka, Kazuhiko Nakagawa

研究成果: Contribution to journal › Article › 査読

本文言語	英語
ページ（範囲）	e322-e323
ジャーナル	Journal of Clinical Oncology
巻	31
号	19
DOI	https://doi.org/10.1200/JCO.2012.46.4305
出版ステータス	出版済み - 7 1 2013
外部発表	はい

All Science Journal Classification (ASJC) codes

@article{c6d29774989d45bc8838315f90ef7789,

title = "Clinical response to crizotinib retreatment after acquisition of drug resistance",

author = "Hiromichi Matsuoka and Takayasu Kurata and Isamu Okamoto and Hiroyasu Kaneda and Kaoru Tanaka and Kazuhiko Nakagawa",

year = "2013",

month = jul,

day = "1",

doi = "10.1200/JCO.2012.46.4305",

language = "English",

volume = "31",

pages = "e322--e323",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "19",

}

TY - JOUR

T1 - Clinical response to crizotinib retreatment after acquisition of drug resistance

AU - Matsuoka, Hiromichi

AU - Kurata, Takayasu

AU - Okamoto, Isamu

AU - Kaneda, Hiroyasu

AU - Tanaka, Kaoru

AU - Nakagawa, Kazuhiko

PY - 2013/7/1

Y1 - 2013/7/1

UR - http://www.scopus.com/inward/record.url?scp=84883112344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883112344&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.46.4305

DO - 10.1200/JCO.2012.46.4305

M3 - Article

C2 - 23715571

AN - SCOPUS:84883112344

VL - 31

SP - e322-e323

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 19

ER -